Table 3.

Clinical details of children and binocular outcomes (reporting unit: children)

Reporting unit: children	Laser							Anti-VEGF antibody
	APROP, N = 8	Type 1, N = 96	Type 2 plus, N = 39	Type 2, N = 6	Mild, N = 2	Partial retinal detachment, N = 2	Total, N = 153	APROP, N = 2	Type 1, N = 11	Type 2 plus, N = 1	Total, N = 14
Gestational age at birth, median (IQR)	25.1 (24.3–25.9)	25.1 (24.4–26)	25.3 (24.4–26.4)	25.2 (24.7–26.6)	26.1 (25.9–26.3)	24.4 (24–24.7)	25.1 (24.4–26)	24.9 (24.4–25.4)	24.9 (23.7–25.9)	27.6	25.1 (24.3–25.9)
Birth weight (g), median (IQR)	680 (630–840)	715 (641–824)	740 (660–830)	721 (670–850)	781 (752–810)	622 (610–634)	716 (642–830)	723 (655–790)	590 (565–710)	780	625 (585–757)
Proportion of female children, n (%)	4 (50)	45 (46.9)	15 (38.5)	3 (50)	1 (50)	1 (50)	69 (45.1)	1 (50)	6 (54.6)	0	7 (50)
Age at first treatment (days), median (IQR)	70 (63–73)	83 (73–97)	78 (68–92), n = 38	85 (83–93)	137 (111–163)	82 (80–83)	81 (71–96), n = 152	74 (71–76)	73 (66–80)	64	72 (66–80)
Age at follow-up visit (years), median (IQR)	1.5 (1.2–1.6) n = 5	1.1 (1.0–1.4), n = 84	1.2 (1.0–1.5), n = 36	1.3 (1.1–1.9), n = 5	1.4 (1.4–1.5)	1.2, n = 1	1.2 (1.0–1.5), n = 133	1.0, n = 1	1.2 (0.9–1.5), n = 9	1.2	1.2 (0.9–1.5), n = 11
Children with anisometropia of 1 D or more, n (%)	1 (25) n = 4	12 (17.7), n = 68	6 (22.2), n = 27	0, n = 3	1 (50)	0, n = 1	20 (19), n = 105	0, n = 1	5 (62.5), n = 8	0	5 (50), n = 10
Anisometropia, median (IQR), n (%)	0.5 (0.31–0.75) n = 4	0.25 (0–0.69), n = 68	0 (0–0.5), n = 27	0 (0–0.63), n = 3	1 (0–2)	0, n = 1	0.13 (0–0.63), n = 105	0, n = 1	1 (0.13–1.75), n = 8	0	0.63 (0–1.25), n = 10
Glasses prescribed, n (%)	2 (50) n = 4	15 (21.1), n = 71	3 (12), n = 25	0, n = 5	0, n = 1	1 (100), n = 1	21 (19.6), n = 107	0, n = 1	3 (42.9), n = 7	0	3 (33.3), n = 9
Manifest strabismus, n (%)	2 (40), n = 5	15 (18.1), n = 83	6 (16.2), n = 37	1 (20), n = 5	0, n = 2	1 (100), n = 1	25 (18.8), n = 133	0, n = 1	2 (22.2), n = 9	0	2 (18.2), n = 11
Nystagmus	2	8	1			1	12		1		1